RM, S., PW, M., RA, L., & R, C. (2018). Midostaurin: Its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. Blood advances, 2(4), 444. https://doi.org/10.1182/bloodadvances.2017011080
Chicago Style (17th ed.) CitationRM, Stone, Manley PW, Larson RA, and Capdeville R. "Midostaurin: Its Odyssey from Discovery to Approval for Treating Acute Myeloid Leukemia and Advanced Systemic Mastocytosis." Blood Advances 2, no. 4 (2018): 444. https://doi.org/10.1182/bloodadvances.2017011080.
MLA (9th ed.) CitationRM, Stone, et al. "Midostaurin: Its Odyssey from Discovery to Approval for Treating Acute Myeloid Leukemia and Advanced Systemic Mastocytosis." Blood Advances, vol. 2, no. 4, 2018, p. 444, https://doi.org/10.1182/bloodadvances.2017011080.